Table 1 Demographic and clinical data of cancer patients included in the study
Feature | N (%) | Gastric cancer N = 49 (56%) | Esophagogastric junction cancer N = 38 (44%) | X2 p |
|---|---|---|---|---|
Age (n = 87) | ||||
< 62 | 39 (45) | 24 (62) | 15 (38) | 0.782 |
≥ 62 | 48 (55) | 25 (52) | 23 (48) | 0.38 |
Gender (n = 87) | ||||
Male | 72 (83) | 41 (57) | 31 (43) | 0.066 |
Female | 15 (17) | 8 (53) | 7 (47) | 0.8 |
Histopathological diagnosis (n = 76) | ||||
Tubular | 33 (43) | 21 (64) | 12 (36) | 12.263 |
Mucinous | 9 (12) | 2 (22) | 7 (78) | |
Poorly cohesive | 20 (26) | 13 (65) | 7 (35) | |
Poorly differentiated | 7 (9) | 7 (100) | 0 (0) | |
No data | 7 (9) | 6 (86) | 1 (14) | 0.015 |
Laurent type (n = 75) | ||||
Intestinal | 21 (28) | 17 (81) | 4 (19) | 11.802 |
Diffuse | 15 (20) | 13 (87) | 2 (13) | |
Mixed | 7 (9) | 4 (57) | 3 (43) | |
No data | 32 (43) | 14 (44) | 18 (56) | 0.008 |
Grading (n = 75) | ||||
G1 | 3 (4) | 1 (33) | 2 (67) | 9.391 |
G2 | 33 (44) | 16 (48) | 17 (52) | |
G3 | 28 (37) | 23 (82) | 5 (18) | |
G4 | 1 (1) | 1 (100) | 0 (0) | |
No data | 10 (13) | 7 (70) | 3 (30) | 0.052 |
cTNM (n = 75) | ||||
IA-IIIA | 27 (36) | 21 (78) | 6 (22) | 3.476 |
IIIB-IV | 48 (63) | 27 (56) | 21 (44) | 0.062 |
IHC results (n = 19) | ||||
Negative | 9 (47) | 5 (56) | 4 (44) | 0.445 |
Low expression of HER2 (+ or ++) | 7 (37) | 5 (71) | 2 (29) | |
High expression of HER2 (+++) | 3 (16) | 2 (67) | 1 (33) | 0.8 |
Treatment (n = 87) | ||||
PAL | 26 (30) | 17 (65) | 9 (35) | 63.079 |
CHTH | 3 (3) | 3 (100) | 0 (0) | |
CHRTH | 5 (6) | 0 (0) | 5 (100) | |
CHTH + OP | 29 (33) | 29 (100) | 0 (0) | |
CHRTH + OP | 9 (10) | 0 (0) | 9 (100) | |
OP | 15 (17) | 0 (0) | 15 (100) | < 0.00000 |